Human Immunotherapy Luminex® Performance Assay 24-plex Fixed Panel
Discontinued Product
LKTM010 has been discontinued and is replaced by LKTM010B.
U.S. orders usually ship in 1-2 business days
Human Immunotherapy Luminex® Performance Assay 24-plex Fixed Panel Summary
| Assay Type | bead-based multiplex assay for the Luminex® platform |
| Format | 1 x 96-well microplate and antibody-coated beads |
| Analytes Detected | Please see analyte list in assay customization tool below. |
| Performance Validation | Luminex Assays are validated for use with cell culture supernatants, plasma and serum. All Luminex assays are tested for sensitivity, intra-assay precision, inter-assay precision and to ensure assay linearity for validated sample types. Antibody pairs are selected and tested to confirm the parallel detection of natural and recombinant standard protein and to ensure the accurate determination of target analytes within biological samples. Assays for each target analyte are screened against all target analytes to confirm low antibody cross-reactivity. |
Not finding your analyte of interest? View our complete Luminex offering in the full version of our Luminex Assay Customization Tool. We also offer Custom Luminex Services.
Precision
|
Intra-Assay Precision - is generated from the mean of the %CV's from 40 reportable results across two different concentrations of analytes in a single serum assay Inter-Assay Precision - is generated from the mean of the %CV's across two different concentrations of analytes across 25 different serum assays. |
||
| n=40 (20x2 levels) | n=25 | |
|---|---|---|
| Analyte | Intra-Assay (%CV) | Inter-Assay (%CV) |
| B7-H1/PD-L1 | 1.8% | 11.3% |
| CCL2/MCP-1 | 1.4% | 8.9% |
| CCL3/MIP-1alpha | 1.5% | 7.3% |
| CCL4/MIP-1beta | 3.0% | 9.6% |
| CD40 Ligand | 3.3% | 10.6% |
| CXCL10/IP-10 | 2.1% | 8.8% |
| CXCL8/IL-8 | 1.8% | 9.0% |
| GM-CSF | 3.1% | 10.3% |
| Granzyme B | 1.8% | 11.0% |
| IFN-alpha | 2.9% | 9.9% |
| IFN-gamma | 2.8% | 10.4% |
| IL-10 | 3.3% | 9.0% |
| IL-12 p70 | 2.3% | 10.5% |
| IL-13 | 1.6% | 9.7% |
| IL-15 | 2.4% | 9.9% |
| IL-17A | 2.5% | 11.2% |
| IL-1alpha | 3.0% | 10.4% |
| IL-1beta | 2.3% | 10.0% |
| IL-1ra | 2.1% | 10.3% |
| IL-2 | 2.2% | 9.2% |
| IL-33 | 2.4% | 12.3% |
| IL-4 | 3.2% | 9.7% |
| IL-6 | 2.6% | 9.8% |
| TNF-alpha | 2.2% | 8.7% |
Accuracy
|
Linearity - The data represents mean spiked or natural linearity in serum matrix samples. Samples with natural linearity are marked with an astrisk. Spike Recovery - The data represents mean percent recovery of spiked standards ranging from low, medium, and high concentration in serum matrix samples. |
||||
| Linearity | Spiked Recovery |
|||
|---|---|---|---|---|
| Analyte | N | Average % | N | Average % |
|
*Natural linearity |
||||
| B7-H1/PD-L1 | 4 | 106% | 4 | 109% |
| CCL2/MCP-1 | 4* | 82% | High endogenous | |
| CCL3/MIP-1alpha | 4 | 77% | 4 | 139% |
| CCL4/MIP-1beta | 4 | 103% | 4 | 111% |
| CD40 Ligand | 4 | 113% | 4 | 100% |
| CXCL10/IP-10 | 3 | 110% | High endogenous | |
| CXCL8/IL-8 | 4 | 118% | 4 | 96% |
| GM-CSF | 4 | 96% | 4 | 110% |
| Granzyme B | 4 | 99% | 4 | 118% |
| IFN-alpha | 3 | 98% | 4 | 101% |
| IFN-gamma | 4 | 97% | 4 | 112% |
| IL-10 | 4 | 111% | 4 | 104% |
| IL-12 p70 | 4 | 106% | 4 | 108% |
| IL-13 | 4 | 112% | 4 | 103% |
| IL-15 | 3 | 88% | 3 | 89% |
| IL-17A | 4 | 110% | 4 | 106% |
| IL-1alpha | 4 | 143% | 4 | 80% |
| IL-1beta | 4 | 107% | 4 | 99% |
| IL-1ra | 4* | 100% | 4 | 145% |
| IL-2 | 4 | 105% | 4 | 102% |
| IL-33 | 4 | 93% | 4 | 110% |
| IL-4 | 3 | 127% | 3 | 77% |
| IL-6 | 3 | 124% | 3 | 90% |
| TNF-alpha | 4 | 117% | 4 | 69% |
Assays for the Luminex platform are offered as High Performance Assays or Assays. The Luminex High Performance Assays are fully validated panels with a focused selection of analytes. They are available in We Mix, You Mix, and Predetermined formats. The Luminex Assays allows for the maximum number of analytes in a multiplex and is supplied as a premixed kit. View a table comparing the features and benefits of these bead-based multiplex assays.
Scientific Data
Product Datasheets
Citations for Human Immunotherapy Luminex® Performance Assay 24-plex Fixed Panel
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
3
Citations: Showing 1 - 3
Filter your results:
Filter by:
-
Stretch Causes cffDNA and HMGB1-Mediated Inflammation and Cellular Stress in Human Fetal Membranes
Authors: Padron, JG;Saito Reis, CA;Ng, PK;Norman Ing, ND;Baker, H;Davis, K;Kurashima, C;Kendal-Wright, CE;
International journal of molecular sciences
Species: Human
Sample Types: Cell Culture Supernates
-
Generation and Functional Characterization of PLAP CAR-T Cells against Cervical Cancer Cells
Authors: V Yekehfalla, S Pahlavanne, A Sayadmanes, Z Momtahan, B Ma, M Basiri
Biomolecules, 2022-09-14;12(9):.
Species: Human
Sample Types: Cell Culture Supernatants
-
Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity
Authors: M Vono, A Huttner, S Lemeille, P Martinez-M, B Meyer, S Baggio, S Sharma, A Thiriard, A Marchant, GJ Godeke, C Reusken, C Alvarez, F Perez-Rodr, I Eckerle, L Kaiser, N Loevy, CS Eberhardt, G Blanchard-, CA Siegrist, AM Didierlaur
Cell Reports, 2021-09-15;0(0):109773.
Species: Human
Sample Types: Plasma
FAQs
No product specific FAQs exist for this product, however you may
View all Luminex Assay FAQsReviews for Human Immunotherapy Luminex® Performance Assay 24-plex Fixed Panel
There are currently no reviews for this product. Be the first to review Human Immunotherapy Luminex® Performance Assay 24-plex Fixed Panel and earn rewards!
Have you used Human Immunotherapy Luminex® Performance Assay 24-plex Fixed Panel?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
